Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Zhuang

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Bioorganic & Medicinal Chemistry|May 23, 2025
Advances in MLKL-targeted inhibitors and PROTACs for necroptosis therapeuticsPengcheng Dai, Yufeng Xin, Xiuting Qin, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitorsYuFeng Xin, Pengcheng Dai, Hongming Shao, et al.
Bioorganic Chemistry|February 2, 2020
Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseYali Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|January 15, 2014
Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure searchChunlin Zhuang, Sreekanth Narayanapillai, Wannian Zhang, et al.
Bioorganic Chemistry|April 25, 2021
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activityYali Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|November 2, 2023
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting ActivityJing-Jie Fang, Hou-Zong Yao, Chunlin Zhuang, et al.
European Journal of Medicinal Chemistry|September 26, 2024
Peptide inhibitors targeting Ras and Ras-associated protein-protein interactionsDan Han, Anpeng Li, Lie Zhu, et al.
Journal of Medicinal Chemistry|June 28, 2022
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein DegradationJianyu Yan, Tengfei Li, Zhenyuan Miao, et al.
European Journal of Medicinal Chemistry|December 24, 2018
Small molecule-drug conjugates: A novel strategy for cancer-targeted treatmentChunlin Zhuang, Xianghong Guan, Hao Ma, et al.
Bioorganic Chemistry|April 26, 2020
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1Yang Yang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry|May 23, 2025
Advances in MLKL-targeted inhibitors and PROTACs for necroptosis therapeuticsPengcheng Dai, Yufeng Xin, Xiuting Qin, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitorsYuFeng Xin, Pengcheng Dai, Hongming Shao, et al.
Bioorganic Chemistry|February 2, 2020
Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseYali Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|January 15, 2014
Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure searchChunlin Zhuang, Sreekanth Narayanapillai, Wannian Zhang, et al.
Bioorganic Chemistry|April 25, 2021
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activityYali Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry|November 2, 2023
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting ActivityJing-Jie Fang, Hou-Zong Yao, Chunlin Zhuang, et al.
European Journal of Medicinal Chemistry|September 26, 2024
Peptide inhibitors targeting Ras and Ras-associated protein-protein interactionsDan Han, Anpeng Li, Lie Zhu, et al.
Journal of Medicinal Chemistry|June 28, 2022
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein DegradationJianyu Yan, Tengfei Li, Zhenyuan Miao, et al.
European Journal of Medicinal Chemistry|December 24, 2018
Small molecule-drug conjugates: A novel strategy for cancer-targeted treatmentChunlin Zhuang, Xianghong Guan, Hao Ma, et al.
Bioorganic Chemistry|April 26, 2020
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1Yang Yang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 15